Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain.
PLoS One
; 14(11): e0225061, 2019.
Article
in En
| MEDLINE
| ID: mdl-31714950
Full text:
1
Database:
MEDLINE
Main subject:
Antiviral Agents
/
HIV Infections
/
Hepatitis C, Chronic
Type of study:
Observational_studies
/
Prognostic_studies
Country/Region as subject:
Europa
Language:
En
Year:
2019
Type:
Article